SLC7A5 and malignant colon neoplasm: In 2010, Oda et al. published a compound (KYT-0353 or JPH203) that selectively inhibited LAT1 with an IC50 value of 0.06 μM in HT-29 colon cancer cells that did not block LAT2 at this concentration [79].